Trv Gp Iv, Llc sold $4.8M of Tango Therapeutics (TNGX)

Executed Oct 23 2025, disclosed Oct 27 2025, 4 days later.

Value, as filed

$4.8M

477,401 sh × $10.15

Executed

Oct 23 2025

the trade date, as filed

Disclosed

Oct 27 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TL Trv Gp Iv, Llc 10% owner profile →

Trv Gp Iv, Llc (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in Tango Therapeutics, Inc. (TNGX). The largest single filing was $4.8M of TNGX (477,401 sh × $10.15, as filed), executed Oct 23 2025.

The name

TNGX

Tango Therapeutics, Inc. TNGX · Healthcare · 23 filings in 24 months ticker →

Healthcare · Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations wi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Trv Gp Iv, Llc in TNGX

TNGXSALE Tango Therapeutics, Inc. $4.0M
500,000 sh × $8.02
Exec Sep 25 2025
Filed Sep 29 2025 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $2.6M
363,541 sh × $7.04
Exec Sep 16 2025
Filed Sep 17 2025 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $5.1M
729,365 sh across 2 lots
Exec Sep 5 2025
Filed Sep 9 2025 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $710K
67,400 sh × $10.53
Exec Sep 13 2024
Filed Sep 17 2024 · 5:30 PM ET TNGXSALE Tango Therapeutics, Inc. $867K
75,000 sh × $11.56
Exec Sep 5 2024
Filed Sep 9 2024 · 5:30 PM ET